Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-7607

Colorectal Cancer Screening and Guardant Shield blood test

XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Hide
      Thank you for your inquiry regarding CMS130v13 (2025 Performance Period). This measure is based on the guidelines from the U.S. Preventive Services Task Force (USPSTF), which does not recognize the CRC blood test as an acceptable option for meeting the measure's criteria.

      To meet the numerator requirements, applicable screenings include Fecal Occult Blood Test, Stool DNA with Fecal Immunochemical Test (FIT), Flexible Sigmoidoscopy, CT Colonography, or a colonoscopy. Clinically equivalent services may be mapped to the codes used in a measure's value sets to satisfy a value set requirement. If mapping is conducted, you should maintain documentation in case of a CMS audit. Please review the measure specification for further details about measure requirements: https://ecqi.healthit.gov/sites/default/files/ecqm/measures/CMS130v13.html.

      Show
      Thank you for your inquiry regarding CMS130v13 (2025 Performance Period). This measure is based on the guidelines from the U.S. Preventive Services Task Force (USPSTF), which does not recognize the CRC blood test as an acceptable option for meeting the measure's criteria. To meet the numerator requirements, applicable screenings include Fecal Occult Blood Test, Stool DNA with Fecal Immunochemical Test (FIT), Flexible Sigmoidoscopy, CT Colonography, or a colonoscopy. Clinically equivalent services may be mapped to the codes used in a measure's value sets to satisfy a value set requirement. If mapping is conducted, you should maintain documentation in case of a CMS audit. Please review the measure specification for further details about measure requirements: https://ecqi.healthit.gov/sites/default/files/ecqm/measures/CMS130v13.html .
    • CMS0130v13
    • Medicare is covering new FDA approved CRC blood test from Guardant Health. if prescribed, this is not counting towards quality numerator

      Medicare is covering new FDA approved CRC blood test from Guardant Health, FDA approval in 2024.  if prescribed, this is not counting towards quality numerator as it is not a numerator compliant screening listed in the measure specifications.  Will CMS begin including this screening tool in their specifications for this measure since Medicare is covering it as a screening tool?

            AIR EC eCQM Team AIR EC eCQM Team
            sshillinger Sean Shillinger
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: